Serum albumin binding proteins
AssigneeAblynx N.V.
InventorsBruno Dombrecht, Peter Schotte, Cedric Josef Neotere Ververken
Life of this patent
Estimating the term…
Abstract
The present invention relates to amino acid sequences that are capable of binding to serum albumin; to proteins and polypeptides comprising or essentially consisting of such amino acid sequences; to nucleic acids that encode such amino acid sequences, proteins or polypeptides; to compositions, and in particular pharmaceutical compositions, that comprise such amino acid sequences, proteins and polypeptides; and to uses of such amino acid sequences, proteins and polypeptides.
Claims21
Polypeptide, protein, construct, compound or other chemical entity that comprises or essentially consists of the amino acid sequence Alb-23 (SEQ ID NO:1) or a variant of Alb-23 and one or more (such as one or two) other amino acid sequences, binding domains, binding units or other moieties or chemical entities, suitably linked to each other either directly or optionally via one or more suitable linkers or spacers.
(canceled)
Dependencies are inferred from the claim text.